CAR-T trial deaths do not deter lupus patients hoping for a cure
In short
Clinical trials evaluating CAR-T therapy for lupus have reported patient fatalities during testing. Despite these documented dangers, patient interest in accessing the experimental treatment has not diminished. Individuals diagnosed with the condition continue to pursue enrollment because they are seeking a cure for the illness.
Key points
- Serious clinical safety events have failed to deter individuals who are hoping for a perm…: Serious clinical safety events have failed to deter individuals who are hoping for a permanent cure.
- Ongoing demand demonstrates that some lupus patients are willing to accept substantial me…: Ongoing demand demonstrates that some lupus patients are willing to accept substantial medical dangers.
- Interest in participating in experimental CAR-T trials continues despite the confirmation…: Interest in participating in experimental CAR-T trials continues despite the confirmation of trial deaths.